1. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
   Afshin Taheriazam et al, 2023, European Journal of Pharmacology CrossRef
2. Research on the expression of Mir-218-2 in the serum of patients with papillary thyroid cancer and its clinical significance
   Haoting He et al, 2024, European Journal of Translational Myology CrossRef
3. Advances in the Biological Functions and Mechanisms of miRNAs in the Development of Osteosarcoma
   Zihe Dong et al, 2022, Technology in Cancer Research & Treatment CrossRef
4. HK2 and LDHA upregulation mediate hexavalent chromium-induced carcinogenesis, cancer development and prognosis through miR-218 inhibition
   Lin Wang et al, 2024, Ecotoxicology and Environmental Safety CrossRef
5. Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways
   Xi Xiao et al, 2023, Thyroid® CrossRef
6. MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities
   Xiaojuan Tang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
7. Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment
   Zaixiang Fu et al, 2022, Frontiers in Oncology CrossRef
8. Revisiting the Tenascins: Exploitable as Cancer Targets?
   Richard P. Tucker et al, 2022, Frontiers in Oncology CrossRef
9. Tenascin-C: A Key Regulator in Angiogenesis during Wound Healing
   Yucai Wang et al, 2022, Biomolecules CrossRef
10. Tenascin-C targeting strategies in cancer
    Sayda Dhaouadi et al, 2024, Matrix Biology CrossRef
11. Terpinen-4-ol Induces Ferroptosis of Glioma Cells via Downregulating JUN Proto-Oncogene
    Wenpeng Cao et al, 2023, Molecules CrossRef